Pharsight

Oxaydo patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US7510726 ZYLA Methods and compositions for deterring abuse of opioid containing dosage forms
Nov, 2023

(6 months ago)

US7981439 ZYLA Methods and compositions for deterring abuse of drugs susceptible to abuse and dosage forms thereof
Nov, 2023

(6 months ago)

US8637540 ZYLA Compositions for deterring abuse of opioid containing dosage forms
Nov, 2023

(6 months ago)

US8409616 ZYLA Extended release opioid abuse deterrent compositions and methods of making same
Nov, 2023

(6 months ago)

US9492443 ZYLA Abuse deterrent compositions and methods of making same
May, 2024

(18 days ago)

US7201920 ZYLA Methods and compositions for deterring abuse of opioid containing dosage forms
Mar, 2025

(9 months from now)

Oxaydo is owned by Zyla.

Oxaydo contains Oxycodone Hydrochloride.

Oxaydo has a total of 6 drug patents out of which 5 drug patents have expired.

Expired drug patents of Oxaydo are:

  • US7510726
  • US7981439
  • US8637540
  • US8409616
  • US9492443

Oxaydo was authorised for market use on 17 June, 2011.

Oxaydo is available in tablet;oral dosage forms.

The generics of Oxaydo are possible to be released after 16 March, 2025.

Stay ahead of others in designing the generic launch strategy of these 5 blockbuster drugs expiring in next 5 years.

Get the exclusive patent insights now. Don't be the last to know.

Drugs and Companies using OXYCODONE HYDROCHLORIDE ingredient

Market Authorisation Date:

17 June, 2011

Treatment:

NA

Dosage:

TABLET;ORAL

How can I launch a generic of OXAYDO before its drug patent expiration?

More Information on Dosage

OXAYDO family patents

Family Patents